Annual Report 2017

April 16, 2018

What to Expect from This Document?

Better known up until a few years ago for its bioseparation and enabling of manufacturing of biopharmaceuticals expertise, Prometic has during 2017, continued its transition that has transformed the company into a biopharmaceutical corporation with two drug discovery platforms focusing on rare and orphan diseases representing significant and unmet medical needs.

Previous Flipbook
Annual Report 2018
Annual Report 2018

2018 was once again a year filled with strong scientific and clinical program development achievements for ...

Next Flipbook
2016 Annual Report
2016 Annual Report

Prometic is only months away from becoming a fully integrated biopharmaceutical company.